Literature DB >> 21848458

The doctor's dilemma--what is "appropriate" care?

Victor R Fuchs1.   

Abstract

Mesh：

Year:  2011        PMID： 21848458     DOI： 10.1056/NEJMp1107283

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  12 in total

Review 1.  Moving molecular targeted drug therapy towards personalized medicine: issues related to clinical trial design.

Authors:  Jaap Verweij; Maja de Jonge; Ferry Eskens; Stefan Sleijfer
Journal:  Mol Oncol       Date:  2012-02-16       Impact factor: 6.603

2.  Sharing individual research results with biospecimen contributors: counterpoint.

Authors:  Ellen Wright Clayton
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-02       Impact factor: 4.254

3.  Twenty-four-hour intensivist staffing in teaching hospitals: tensions between safety today and safety tomorrow.

Authors:  Meeta Prasad Kerlin; Scott D Halpern
Journal:  Chest       Date:  2012-05       Impact factor: 9.410

4.  Addressing the Concerns Surrounding Continuous Deep Sedation in Singapore and Southeast Asia: A Palliative Care Approach.

Authors:  Lalit Kumar Radha Krishna
Journal:  J Bioeth Inq       Date:  2015-07-15       Impact factor: 1.352

5.  Impedance of novel therapeutic technologies: the case of stem cells.

Authors:  David G Zacharias; Timothy J Nelson; Paul S Mueller; C Christopher Hook
Journal:  Clin Transl Sci       Date:  2012-06-28       Impact factor: 4.689

6.  The Pitfalls of Overtreatment: Why More Care is not Necessarily Beneficial.

Authors:  Kanny Ooi
Journal:  Asian Bioeth Rev       Date:  2020-08-19

7.  Home Visit-Based Community Paramedicine and Its Potential Role in Improving Patient-Centered Primary Care: A Grounded Theory Study and Framework.

Authors:  Katie N Dainty; M Bianca Seaton; Ian R Drennan; Laurie J Morrison
Journal:  Health Serv Res       Date:  2018-03-15       Impact factor: 3.402

8.  Treatment of nonfatal conditions at the end of life: nonmelanoma skin cancer.

Authors:  Eleni Linos; Rupa Parvataneni; Sarah E Stuart; W John Boscardin; C Seth Landefeld; Mary-Margaret Chren
Journal:  JAMA Intern Med       Date:  2013-06-10       Impact factor: 21.873

Review 9.  Conceptual, methodological, and ethical problems in communicating uncertainty in clinical evidence.

Authors:  Paul K J Han
Journal:  Med Care Res Rev       Date:  2012-11-06       Impact factor: 3.929

10.  Guidelines on the clinical use for the detection of neutralizing antibodies (NAbs) to IFN beta in multiple sclerosis therapy: report from the Italian Multiple Sclerosis Study group.

Authors:  Antonio Bertolotto; Marco Capobianco; Maria Pia Amato; Elisabetta Capello; Ruggero Capra; Diego Centonze; Maria Di Ioia; Antonio Gallo; Luigi Grimaldi; Luisa Imberti; Alessandra Lugaresi; Chiara Mancinelli; Maria Giovanna Marrosu; Lucia Moiola; Enrico Montanari; Silvia Romano; Luigina Musu; Damiano Paolicelli; Francesco Patti; Carlo Pozzilli; Silvia Rossi; Marco Salvetti; Gioachino Tedeschi; Maria Rosaria Tola; Maria Trojano; Maria Troiano; Mauro Zaffaroni; Simona Malucchi
Journal:  Neurol Sci       Date:  2013-12-29       Impact factor: 3.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.